Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 19, 2021 Filed Feb 22, 2021 21:32 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000146 · wf-form4_161402953083682.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,704

Underlying: Common Stock · 6,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 6,000 options granted February 19, 2016 at an exercise price of $41.83 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 1,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; and 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
February 19, 2021 Filed Feb 22, 2021 21:32 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 6,000 $167.88 $1,007,280.00
Disclosure

SEC source: 0001555280-21-000146 · wf-form4_161402953083682.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,083

Read SEC document
February 19, 2021 Filed Feb 22, 2021 21:32 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 6,000 $41.83 $250,980.00
Disclosure

SEC source: 0001555280-21-000146 · wf-form4_161402953083682.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,083

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 23:47 UTC PurchaseCommon Stock 2,100 $165.48 $347,508.00
Disclosure

SEC source: 0001555280-21-000150 · wf-form4_161412403100072.xml · nonDerivative · entry 3

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 7,590

F4 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $165.25 to $165.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's spouse is a co-trustee of the trust.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 23:47 UTC PurchaseCommon Stock 2,900 $164.89 $478,181.00
Disclosure

SEC source: 0001555280-21-000150 · wf-form4_161412403100072.xml · nonDerivative · entry 2

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 5,490

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $164.25 to $165.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's spouse is a co-trustee of the trust.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 23:47 UTC PurchaseCommon Stock 2,590 $163.80 $424,242.00
Disclosure

SEC source: 0001555280-21-000150 · wf-form4_161412403100072.xml · nonDerivative · entry 1

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 2,590

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $163.26 to $164.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held in a trust for the benefit of the reporting person's daughter. The reporting person's spouse is a co-trustee of the trust.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 21:59 UTC Exercise / conversionStock Option · Derivative 133,070 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · derivative · entry 5

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,192

Underlying: Common Stock · 133,070 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 133,070 options granted February 13, 2018 at an exercise price of $73.24 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 110,192 options granted February 12, 2019 at an exercise price of $87.51 per option.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 21:59 UTC SaleCommon Stock 3,000 $161.76 $485,280.00
Disclosure

SEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 4

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 214,307

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.68 to $161.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 21:59 UTC SaleCommon Stock 63,029 $160.89 $10,140,735.81
Disclosure

SEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 3

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,307

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.48 to $161.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 21:59 UTC SaleCommon Stock 67,041 $160.17 $10,737,956.97
Disclosure

SEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 2

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,336

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.48 to $160.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 21:59 UTC Exercise / conversionCommon Stock 133,070 $73.24 $9,746,046.80
Disclosure

SEC source: 0001555280-21-000148 · wf-form4_161411752409881.xml · nonDerivative · entry 1

Alaix Juan Ramon · CIK 0001567824 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:31 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 600 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000145 · wf-form4_161402948522749.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,027

Underlying: Common Stock · 600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 600 options granted February 14, 2017 at an exercise price of $55.02 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 23,875 options granted February 14, 2017 at an exercise price of $55.02 per option; 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option; 14,921 options granted February 12,2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 8,758 options granted February 10, 2021 at an exercise price of $160.62 per option .

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:31 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 600 $170.04 $102,024.00
Disclosure

SEC source: 0001555280-21-000145 · wf-form4_161402948522749.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,645

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.03 to $170.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 18, 2021 Filed Feb 22, 2021 21:31 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 600 $55.02 $33,012.00
Disclosure

SEC source: 0001555280-21-000145 · wf-form4_161402948522749.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2020.

Read SEC document
February 17, 2021 Filed Feb 18, 2021 21:54 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionStock Option · Derivative 3,285 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · derivative · entry 3

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,466

Underlying: Common Stock · 3,285 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 3,285 options granted February 13, 2018 at an exercise price of $73.24 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 9,857 options granted February 13, 2018 at an exercise price of $73.24 per option; 13,774 options granted February 12, 2019 at an exercise price of $87.51 per option; 9,581 options granted February 11, 2020 at an exercise price of $144.03 per option; and 9,254 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
February 17, 2021 Filed Feb 18, 2021 21:54 UTC
Trawicki RomanExecutive Vice President
SaleCommon Stock 4,491 $165.82 $744,697.62
Disclosure

SEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · nonDerivative · entry 2

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,623

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
February 17, 2021 Filed Feb 18, 2021 21:54 UTC
Trawicki RomanExecutive Vice President
Exercise / conversionCommon Stock 3,285 $73.24 $240,593.40
Disclosure

SEC source: 0001555280-21-000141 · wf-form4_161368522661397.xml · nonDerivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,114

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2020.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:56 UTC
David GlennChief Financial Officer
Exercise / conversionStock Option · Derivative 26,285 $0.00 $0.00
Disclosure

SEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · derivative · entry 4

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,510

Underlying: Common Stock · 26,285 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F5 · derivative.exercise_price: 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option.

F6 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F7 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F8 · balance_after: 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 24,678 options granted February 12, 2019 at an exercise price of $87.51 per option; 18,794 options granted February 11, 2020 at an exercise price of $144.03 per option; and 18,326 options granted February 10, 2021 at an exercise price of $160.62 per option.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:56 UTC
David GlennChief Financial Officer
SaleCommon Stock 16,285 $169.35 $2,757,864.75
Disclosure

SEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · nonDerivative · entry 3

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,901

F3 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.00 to $169.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:56 UTC
David GlennChief Financial Officer
SaleCommon Stock 10,000 $168.21 $1,682,100.00
Disclosure

SEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · nonDerivative · entry 2

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,186

F2 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.98 to $168.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2021 Filed Feb 18, 2021 21:56 UTC
David GlennChief Financial Officer
Exercise / conversionCommon Stock 26,285 $73.24 $1,925,113.40
Disclosure

SEC source: 0001555280-21-000142 · wf-form4_161368534701322.xml · nonDerivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:22 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000123 · wf-form4_161360048410255.xml · derivative · entry 3

MCCALLISTER MICHAEL B · CIK 0001018657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:22 UTC OtherCommon Stock 754 $166.71 $125,699.34
Disclosure

SEC source: 0001555280-21-000123 · wf-form4_161360048410255.xml · nonDerivative · entry 2

MCCALLISTER MICHAEL B · CIK 0001018657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,521

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:22 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000123 · wf-form4_161360048410255.xml · nonDerivative · entry 1

MCCALLISTER MICHAEL B · CIK 0001018657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,275

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:36 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000129 · wf-form4_161360140261552.xml · derivative · entry 2

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:36 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000129 · wf-form4_161360140261552.xml · nonDerivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,904

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:31 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000126 · wf-form4_161360105947856.xml · derivative · entry 2

Reed Willie M · CIK 0001601695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:31 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000126 · wf-form4_161360105947856.xml · nonDerivative · entry 1

Reed Willie M · CIK 0001601695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:58 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionPerformance Award Unit · Derivative 10,145.4088 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · derivative · entry 6

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,145.4088 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock.

F2 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F4 · derivative.exercise_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock.

F4 · derivative.expiration_date: Performance award units having a three-year performance period covering 2018-2020 previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 9, 2021, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) vested on February 13, 2021 and were settled in shares of Zoetis common stock.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:58 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Unit · Derivative 6,948.8824 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · derivative · entry 5

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,813.5715

Underlying: Common Stock · 6,948.8824 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 6,948.8824 RSUs vested on February 13, 2021; 5,201.6369 RSUs will vest on February 12, 2022; 13,230.9346 RSUs will vest on February 11, 2023; and 14,381 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:58 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Tax withholdingCommon Stock 4,095 $166.71 $682,677.45
Disclosure

SEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 4

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,351

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:58 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 10,145 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,446

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

F2 · price: Acquisition of common stock upon vesting and settlement of performance award units. Each performance award unit represents a right to receive one share of Zoetis Inc. common stock upon vesting of the performance award unit.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:58 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Tax withholdingCommon Stock 2,521 $166.71 $420,275.91
Disclosure

SEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,301

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:58 UTC
PECK KRISTIN CDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,948 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000137 · wf-form4_161360269475035.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,822

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:24 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · derivative · entry 3

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:24 UTC OtherCommon Stock 697 $166.71 $116,196.87
Disclosure

SEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · nonDerivative · entry 2

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,389.2431

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:24 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000124 · wf-form4_161360064399444.xml · nonDerivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,086.2431

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:35 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000128 · wf-form4_161360128890786.xml · derivative · entry 3

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:35 UTC OtherCommon Stock 997 $166.71 $166,209.87
Disclosure

SEC source: 0001555280-21-000128 · wf-form4_161360128890786.xml · nonDerivative · entry 2

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,589

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:35 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000128 · wf-form4_161360128890786.xml · nonDerivative · entry 1

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,586

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:16 UTC
Bisaro PaulDirector
Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000120 · wf-form4_161360018202240.xml · derivative · entry 2

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F2 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F2 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:16 UTC
Bisaro PaulDirector
Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000120 · wf-form4_161360018202240.xml · nonDerivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,527

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:29 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000125 · wf-form4_161360096129044.xml · derivative · entry 3

PARENT LOUISE M · CIK 0001209456 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:29 UTC OtherCommon Stock 997 $166.71 $166,209.87
Disclosure

SEC source: 0001555280-21-000125 · wf-form4_161360096129044.xml · nonDerivative · entry 2

PARENT LOUISE M · CIK 0001209456 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,236

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:29 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000125 · wf-form4_161360096129044.xml · nonDerivative · entry 1

PARENT LOUISE M · CIK 0001209456 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,233

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:18 UTC Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000121 · wf-form4_161360026953953.xml · derivative · entry 3

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:18 UTC OtherCommon Stock 887 $166.71 $147,871.77
Disclosure

SEC source: 0001555280-21-000121 · wf-form4_161360026953953.xml · nonDerivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,808

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 22:18 UTC Exercise / conversionCommon Stock 2,779 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000121 · wf-form4_161360026953953.xml · nonDerivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:33 UTC
Rhodes LindaDirector
Exercise / conversionRestricted Stock Unit · Derivative 2,779.1458 Not disclosed Not disclosed
Disclosure

SEC source: 0001555280-21-000127 · wf-form4_161360118931056.xml · derivative · entry 3

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,694.57

Underlying: Common Stock · 2,779.1458 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F1 · derivative.exercise_price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F1 · price: Acquisition of common stock upon vesting and settlement of restricted stock units (RSUs). Each RSU represents a right to receive one share of Zoetis Inc. common stock upon vesting of the RSU.

F3 · derivative.exercise_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

F3 · derivative.expiration_date: Restricted stock units previously granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). The RSUs vest as follows and are settled in Zoetis common stock upon vesting: 2,779.1458 RSUs vested on February 13, 2021; 2,658.4794 RSUs will vest on February 12, 2022; 1,605.0906 RSUs will vest on February 11, 2023; and 1,431 RSUs will vest on February 10, 2024.

Read SEC document
February 13, 2021 Filed Feb 17, 2021 17:33 UTC
Rhodes LindaDirector
OtherCommon Stock 612 $166.71 $102,026.52
Disclosure

SEC source: 0001555280-21-000127 · wf-form4_161360118931056.xml · nonDerivative · entry 2

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,635

F2 · kind: Disposition of shares to the Company in exchange for cash based on the closing share price of Zoetis Inc. common stock as of the vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.